ACS goes commercial in Europe
US-based pharmaceutical bioscience company Isolagen yesterday announced commencement of the full commercialisation phase of its European autologous cellular production facility.
News & Analysis on Cosmetics Innovation
US-based pharmaceutical bioscience company Isolagen yesterday announced commencement of the full commercialisation phase of its European autologous cellular production facility.